Bio-Rad Laboratories BIO
NYSE BIO
$376.85 -3.27 (-0.86%)
As of: Sep 9, 2026 · 3:59 PM EDT

Bio-Rad Laboratories (BIO) FCF Margin Growth (5y) (2014 - 2026)

Analysis

Bio-Rad Laboratories (BIO) FCF Margin Growth (5y) (2014 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 226.93 Bn 222.99 Bn 8.34 Bn
2 Danaher 145.94 Bn 141.60 Bn 3.61 Bn
3 Agilent Technologies 42.55 Bn 40.79 Bn 1.04 Bn
4 Illumina 32.95 Bn 31.78 Bn 770.00 Mn
5 Revvity 14.53 Bn 13.51 Bn 416.87 Mn
6 Bio-Techne 11.31 Bn 11.04 Bn 211.39 Mn
7 Bio-Rad Laboratories 10.34 Bn 8.72 Bn 345.80 Mn
8 Repligen 9.46 Bn 8.44 Bn 110.04 Mn
9 Bruker 8.91 Bn 8.73 Bn 416.00 Mn
10 10x Genomics 8.16 Bn 7.61 Bn 112.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -809.00
Mar 31, 2026 25.00
Dec 31, 2025 -1,391.00
Sep 30, 2025 -421.00
Jun 30, 2025 -292.00
Mar 31, 2025 910.00
Dec 31, 2024 -995.00
Sep 30, 2024 675.00
Jun 30, 2024 -1,460.00
Mar 31, 2024 136.00
Dec 31, 2023 -260.00
Sep 30, 2023 110.00
Jun 30, 2023 43.00
Mar 31, 2023 683.00
Dec 31, 2022 -83.00
Sep 30, 2022 -558.00
Jun 30, 2022 -717.00
Mar 31, 2022 2,843.00
Dec 31, 2021 696.00
Sep 30, 2021 2,381.00